rs122453117
Variant summary
Our verdict is Likely pathogenic. Variant got 7 ACMG points: 7P and 0B. PS3_SupportingPP3PM2_SupportingPP4_Strong
This summary comes from the ClinGen Evidence Repository: The NM_005629.4:c.395G>T variant in SLC6A8 is a missense variant that is predicted to result in the substitution of a glycine for a valine at amino acid 132 (p.Gly132Val). This variant has been previously reported one hemizygous male (PMID:17101918, PMID:23644449) who had elevated urinary creatine/creatinine and absent creatine peak on brain MRS (PMID:17101918) (PP4_Strong). This variant was reported to result in <10% creatine transport activity when expressed in SLC6A8-deficient fibroblasts. A creatine concentration of 25uM was used, meeting the requirement for the assay to be carried out with less than or equal to 125uM creatine (PMID:22281021, 23644449) (PS3_Supporting). The variant is absent in gnomAD v2.1.1. (PM2_Supporting). The computational predictor REVEL gives a score of 0.916 which is above the threshold of 0.75, evidence that correlates with impact to SLC6A8 function (PP3). There is a ClinVar entry for this variant (Variation ID: 2290132). In summary, this variant meets criteria to be classified as likely pathogenic for creatine transporter deficiency. ACMG/AMP SLC6A8-specific criteria applied, as specified by the ClinGen CCDS VCEP (Specifications Version 1.1.0): PS3_Supporting, PM2_Supporting, PP3, PP4_Strong.(Classification approved by the ClinGen CCDS VCEP on April 11, 2024) LINK:https://erepo.genome.network/evrepo/ui/classification/CA256014/MONDO:0010305/027
Frequency
Consequence
NM_005629.4 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC6A8 | NM_005629.4 | c.395G>T | p.Gly132Val | missense_variant, splice_region_variant | 3/13 | ENST00000253122.10 | NP_005620.1 | |
SLC6A8 | NM_001142805.2 | c.395G>T | p.Gly132Val | missense_variant, splice_region_variant | 3/13 | NP_001136277.1 | ||
SLC6A8 | NM_001142806.1 | c.50G>T | p.Gly17Val | missense_variant, splice_region_variant | 3/13 | NP_001136278.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC6A8 | ENST00000253122.10 | c.395G>T | p.Gly132Val | missense_variant, splice_region_variant | 3/13 | 1 | NM_005629.4 | ENSP00000253122 | P1 | |
SLC6A8 | ENST00000430077.6 | c.50G>T | p.Gly17Val | missense_variant, splice_region_variant | 3/13 | 2 | ENSP00000403041 | |||
SLC6A8 | ENST00000466243.1 | n.187G>T | non_coding_transcript_exon_variant | 1/2 | 2 | |||||
SLC6A8 | ENST00000675713.1 | n.149G>T | splice_region_variant, non_coding_transcript_exon_variant | 2/3 |
Frequencies
GnomAD3 genomes Cov.: 25
GnomAD4 exome Cov.: 30
GnomAD4 genome Cov.: 25
ClinVar
Submissions by phenotype
Creatine transporter deficiency Pathogenic:2
Pathogenic, no assertion criteria provided | literature only | OMIM | Nov 14, 2006 | - - |
Likely pathogenic, reviewed by expert panel | curation | ClinGen Cerebral Creatine Deficiency Syndromes Variant Curation Expert Panel, ClinGen | Apr 11, 2024 | The NM_005629.4:c.395G>T variant in SLC6A8 is a missense variant that is predicted to result in the substitution of a glycine for a valine at amino acid 132 (p.Gly132Val). This variant has been previously reported one hemizygous male (PMID: 17101918, PMID: 23644449) who had elevated urinary creatine/creatinine and absent creatine peak on brain MRS (PMID: 17101918) (PP4_Strong). This variant was reported to result in <10% creatine transport activity when expressed in SLC6A8-deficient fibroblasts. A creatine concentration of 25uM was used, meeting the requirement for the assay to be carried out with less than or equal to 125uM creatine (PMID: 22281021, 23644449) (PS3_Supporting). The variant is absent in gnomAD v2.1.1. (PM2_Supporting). The computational predictor REVEL gives a score of 0.916 which is above the threshold of 0.75, evidence that correlates with impact to SLC6A8 function (PP3). There is a ClinVar entry for this variant (Variation ID: 2290132). In summary, this variant meets criteria to be classified as likely pathogenic for creatine transporter deficiency. ACMG/AMP SLC6A8-specific criteria applied, as specified by the ClinGen CCDS VCEP (Specifications Version 1.1.0): PS3_Supporting, PM2_Supporting, PP3, PP4_Strong. (Classification approved by the ClinGen CCDS VCEP on April 11, 2024) - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at